Advertisement
LabX
LabX

Taking Aim at Melanoma

Antigen-presenting cells, such as macrophages or dendritic cells, elicit an immune response by displaying tumor antigens bound to the major histocompatibility complex (MHC) to circulating T-cells. Simultaneous T-cell recognition of glycoproteins CD80

By | April 1, 2011

image: Taking Aim at Melanoma Infographic: Boosting T Cell Activation
View full size JPG | PDF
Lucy Reading-Ikkanda

Antigen-presenting cells, such as macrophages or dendritic cells, elicit an immune response by displaying tumor antigens bound to the major histocompatibility complex (MHC) to circulating T-cells. Simultaneous T-cell recognition of glycoproteins CD80 and CD86 on the antigen-presenting cell is also necessary for activation of a T-cell response to antigens (1). After activation, the CTLA4 (cytotoxic T-lymphocyte-associated protein) gene is upregulated and acts to tamp down T-cell activity by binding to CD80/CD86 proteins on the surface of cells presenting antigens (2). The monoclonal antibody ipilimumab is designed to bind to CTLA4 on the surface of regulatory and helper T cells, where it blocks the inhibitory action of CTLA4 and enhances T-cell activity against tumors (3). The therapy has shown some success in patients who do not have BRAF mutations that can be specifically targeted.

 

Read the full story.

Advertisement

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo
Advertisement
QIAGEN ingenuity
QIAGEN ingenuity

Popular Now

  1. Antibody Maker Loses License Over Animal Welfare Violations
  2. ORI: Researcher Faked Dozens of Experiments
    The Nutshell ORI: Researcher Faked Dozens of Experiments

    A former scientist at the University of Michigan and the University of Chicago made up more than 70 experiments on heart cells, according to the Office of Research Integrity.

  3. Immune Defect Detected in Knockout Mice
  4. Exploring Emotional Contagion
Advertisement
Advertisement
Biosearch Technologies
illumina Corporate
illumina Corporate